
Precios mayoristas disponibles para cuentas aprobadas
Thymosin Alpha-1 (Tα1) is a naturally occurring 28-amino acid peptide originally isolated from thymic tissue (Thymosin Fraction 5). It is a potent immunomodulator studied for its ability to enhance T-cell maturation, dendritic cell function, and innate immune responses. Thymosin Alpha-1 is investigated in clinical research for its roles in immune reconstitution, viral hepatitis, immunodeficiency states, and as an adjunct in vaccine immunogenicity studies.
Todos los péptidos de Signal se someten a rigurosas pruebas de terceros y tienen una pureza garantizada ≥99%. Cada lote incluye un Certificado de Análisis (COA) verificado a través del sistema de verificación blockchain de AuthentiChain.
Los pedidos realizados antes de las 12PM EST se envían el mismo día mediante logística de cadena de frío. Los productos se envían en empaques aislados con hielo seco para mantener la integridad de la temperatura. La entrega estándar es de 1 a 3 días hábiles.
Las cuentas aprobadas tienen acceso a términos de pago flexibles que incluyen NET 30, transferencia bancaria y tarjeta de crédito. Los precios basados en volumen se aplican automáticamente al momento del pago según la cantidad de su pedido.
Por supuesto. Contacte a su gerente de cuenta dedicado o escriba a info@signalpeps.co con el nombre del producto y número de lote. Los COA también están disponibles digitalmente a través de nuestra insignia de verificación AuthentiChain en cada página de producto.
In-depth findings from peer-reviewed preclinical and clinical studies
Thymosin Alpha-1 (Tα1) is a naturally occurring 28-amino acid peptide originally isolated from Thymosin Fraction 5 of calf thymus tissue. It is a potent immunomodulator that enhances T-cell differentiation, dendritic cell maturation, and toll-like receptor signaling. Approved in over 35 countries as Zadaxin® for chronic hepatitis B, it is one of the most extensively studied immunomodulatory peptides in clinical research.
Thymosin Alpha-1 promotes the maturation and differentiation of T lymphocytes from bone marrow progenitors, enhancing both CD4+ helper and CD8+ cytotoxic T-cell populations. It restores T-cell function in immunocompromised states and augments T-cell receptor signaling.
Expert Opinion on Biological Therapy (2010)Tα1 activates dendritic cells through toll-like receptor (TLR) 2 and TLR9 signaling, enhancing antigen presentation, cytokine production (IL-12, IFN-α), and bridging innate and adaptive immunity. It also increases natural killer (NK) cell cytotoxicity.
Expert Opinion on Biological Therapy (2010)In multiple randomized controlled trials, Thymosin Alpha-1 demonstrated sustained virological response rates of 26–41% in chronic HBV patients, with HBeAg seroconversion and HBV DNA suppression. It was approved as Zadaxin® for this indication in over 35 countries.
Hepatology Research (2002)Clinical studies showed Thymosin Alpha-1 combined with interferon-alpha produced higher sustained virological response rates in chronic HCV patients compared to interferon monotherapy, particularly in difficult-to-treat genotype 1 populations.
Hepatology Research (2002)Thymosin Alpha-1 has been investigated as an immune adjunct in hepatocellular carcinoma (HCC), melanoma, and non-small cell lung cancer. Studies showed enhanced immune reconstitution after chemotherapy, improved vaccine immunogenicity, and increased tumor-specific immune responses when combined with standard therapies.
International Immunopharmacology (2000)With over 30 years of clinical use across 35+ countries, Thymosin Alpha-1 has demonstrated an excellent safety profile. It does not cause immune overstimulation or autoimmune reactions, and side effects are generally limited to mild injection site reactions. No drug-drug interactions have been reported.
Expert Opinion on Biological Therapy (2010)All findings above are sourced from peer-reviewed journals for educational reference. This product is for research purposes only — not for human consumption. Preclinical results may not translate to human outcomes.
Tres simples pasos para acceder a péptidos de investigación premium
Envíe una solicitud rápida con los datos de su empresa. Toma menos de 2 minutos.
Nuestro equipo revisa las solicitudes en 1–2 días hábiles. Recibirá un correo una vez aprobado.
Explore el catálogo, seleccione cantidades y pague. Los precios por volumen se aplican automáticamente.
Todos los productos son solo para investigación y uso en laboratorio. No destinados para consumo humano o animal. Solo profesionales calificados deben manejar estos productos.